SURYAPHARM

The Exchange has sought clarification from the Company with respect to news item captioned-"CBI Files Case Against Three Directors In Rs. 621-Crore Fraud Involving Punjab And Sindh Bank" In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company

Clarification of News : The press had reports that Surya Pharmaceutical Limited may do a private equity placement to a leading foreign institutional investor at around Rs.250 per share. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Surya Pharmaceutical Limited has vide its letter inter-alia stated, "As on date we do not have any plan of placing equity with any Foreign Institutional Investor on preferential basis"